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Introduction
Thyroid cancer comprises1–5%ofall cancersworldwide.1New
cases of thyroid cancer are diagnosed every year, and this rise
is attributed to the newer diagnostic modalities, such as high-
resolution ultrasonography.2 Papillary, follicular and Hurthle
cell carcinomas of the thyroid fall under the category of well-
differentiated thyroid cancers, and form the bulk of thyroid
malignancies.2 The overall 10-year survival rate of differen-
tiated thyroid cancer lies between 85% and 95%. This number
falls to 50% for patients with distant metastasis.3
The initial presentation of differentiated thyroid malig-
nancy is an increase in the size of the thyroid gland or
otherwise neck swelling; however, in very rare cases, the
patients present with atypical complaints, and after an
evaluation, thyroid malignancy with distant metastasis is
revealed. The literature on this subject is as rare as the cases.
We report a series of cases of patients who presented with
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Abstract Introduction The rates of thyroid cancers are on a rise, especially well-differentiated
thyroid cancers. This could be partly due to newer diagnostic modalities, like high-
resolution ultrasound, that can pick up smaller lesions. Differentiated thyroid cancers
with distant metastases are not common, and even rarer is the initial presentation with
complaints not related to the neck.
Objectives The objective of this series was to study and report the unusual cases of
patients with differentiated thyroid cancer with distant metastasis. There is a lack of
data in the literature on these cases, and due to the rarity of such metastases, no
deﬁnite treatment protocol has been deﬁned.
Methods A retrospective chart review of 1,200 cases of thyroid surgeries was
performed. A total of 10 cases of well-differentiated thyroid cancer on the ﬁnal
histopathology exam that had initially presentedwith usual complaints to departments
other than the Otolaryngology Department were identiﬁed.
Results A total of 6 patients had papillary carcinoma, whereas 4 patients had follicular
carcinoma on ﬁnal the histopathology exam. Two patients presented with iliac crest
lesions, 2 with vertebral lesions one each with parapharyngeal mass, supraclavicular
mass, labia majora swelling and bleeding, lung, rib and neck of femur lesion.
Conclusion There are still no speciﬁc guidelines on how to address these patients with
differentiated thyroid cancer with distant metastasis (except for the cases of bone and
lung lesions) and on which treatment should be offered in case of recurrence. More
studies on the subject are required.
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atypical complaints and were diagnosed with well-differen-
tiated thyroid cancer.
Material and Methods
A retrospective review (descriptive cross-sectional study) of
1,200 cases of patients with thyroid cancer who underwent
treatment at a tertiary care hospital was performed. Well-
differentiated thyroid malignancies with distant metastasis
were found in 10 patients who presented with complains
ranging from lower limb neurological weakness to leg pains.
A total of 8 out of the 10 patients were diagnosed by
departments outsideOtolaryngology, andwere then referred
the right department for the deﬁnitive treatment. All of the
patients underwent surgical resection (thyroidectomy) with
or without neck dissection, and were subsequently referred
to the Endocrinology Department for radioiodine (RAI)
ablation.
Results
A total of 10 patients had distant metastasis at the time of
presentation. Eight out of the 10 patients sought other
specialties at ﬁrst, where a biopsy of the lesion was taken;
after the diagnosis of thyroid malignancy on the histo-
pathology exam, they were then referred to the Department
of Otolaryngology for the deﬁnitive treatment. The mean
age of the patients was 47.80 (standard deviation [SD]:
 9.19) years, and their ages ranged from 35 to 65 years. A
total of 7 patients were male, and the other 3 were female.
Only 1 of the patients underwent total thyroidectomy; 4
underwent total thyroidectomy with central neck dissec-
tion; and 5 patients underwent total thyroidectomy with
bilateral neck dissection. Nine out of the 10 patients under-
went RAI ablation, and 1 patient refused to receive the
treatment. The ﬁnal histopathology exam revealed 6 pa-
tients with papillary carcinoma and 4 patients with folli-
cular carcinoma of the thyroid. Two patients presented with
vertebral lesions and a cystic lesion in the iliac crest. One of
the patients with vertebral lesions had a lower limb weak-
ness that improved over time, but persisted until the last
follow-up. Those patients with iliac crest lesions presented
with leg pain to orthopedic surgeons, and a biopsy under
general anesthesia was performed and revealed a thyroid
malignancy. A female presented to the gynecologist with
bleeding in the labia majora. Two patients presented to a
thoracic surgeon: one of them underwent a trans-thoracic
lung biopsy, and the other underwent a biopsy of a cystic
lesion of the left rib; both were diagnosed with thyroid
malignancy. Another patient presented to an orthopedic
surgeon. A lesion on the right femoral neck was detected
after a computed tomography (CT) scan, and a biopsy was
performed with the patient under general anesthesia. Two
patients presented to our department: one with a right
supraclavicular lesion to whom ﬁne-needle aspiration
cytology (FNAC) was suggested, and the other with oro-
pharyngeal swelling on the left side. An excisional biopsy
revealed a thyroid malignancy.
All of the patients then underwent deﬁnitive surgery, and
were referred to endocrinologists for RAI ablation. A total of 4
patients underwent multiple sessions of RAI ablation over
time, receiving as much as 600 mci.
All of the patients were followed-up regularly, except for
one patient who presented initially with a lesion on her
genitalia. At the time of presentation, she had tumor spread
outside the thyroid gland. The individual cases are summar-
ized in ►Tables 1, 2.
Discussion
Well-differentiated thyroid cancers are usually limited to the
thyroid gland. The rates of distant metastasis are reported to
range from 4–15%.4 Other than the lymph nodes, the most
common sites of metastasis are the lung and bones, but
involvement of other organs is also reported.4 The rate of
metastasis to sites other than the lung and bones is < 5%.3 As
seen in our series, six out of the ten patients had bony
metastasis (two in the iliac crest, two vertebral, and one
each in the rib and femoral neck). To our knowledge, there is
no reported case of metastasis to the labia majora, thus
making our case the ﬁrst to ever be reported.
The presence of distant metastasis at the time of pre-
sentation is a signiﬁcant prognostic factor, as the 10-year
survival rate falls to 50%.4 Age, gender and involvement of
multiple organs are independent factors associated with
mortality in thyroid-cancer patients.4 Metastasis to the
lung and bones are well-understood, and draw signiﬁcant
attention when planning treatment for these patients, but
metastasis outside these organs is usually ignored in the
clinical setting. This may be due to the rarity of such cases,
which explains the lack of literature on the subject.
The prognosis ofwell-differentiated thyroid cancerhas also
been shown to be affected by histopathology, with 10-year
survival rates as high as 90% for papillary thyroid cancer,while
the rates for follicular andHurthle cell carcinomas are 85% and
76% respectively.3,5 The papillary cancer and its variants out-
number follicular and Hurthle cell carcinomas 7-fold 25-fold
respectively.5Papillary thyroid cancer isknown tometastasize
via the lymph nodes, whereas follicular thyroid cancer metas-
tasizeshematogenously,whichcouldexplain itsdistant spread
when compared with papillary thyroid cancer.3 One of our
patients had follicular metastasis to labia majora, and this
could be explained by the hematogenous spread.
A complex understanding is required for the colonization
of thyroid cancer cells in various organs (organ tropism).3
Various models, such as the mitogen-activated protein
kinase (MAPK) and the phosphatidylinositol 3-kinase/pro-
tein kinase B (PI3K/Akt) pathways, have been developed, and
they explain the spread of thyroid cancer to extra-cervical
sites, but they fail to predict the phenomenon of rare organ
metastasis.3 The identiﬁcation of various mediators linked
to metastasis in thyroid cancer in the future will be an
important step to determine organ tropism.6
Blood test for thyroglobulin levels, high-resolution ultra-
sonography, whole body iodine scan, and ﬂuorodeoxyglucose
positron emission tomography (FDG-PET) scan are generally
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used to detect distant metastases in cases of well-differen-
tiated thyroid cancer.3 Elevated thyroglobulin levels during
follow-up suggests a metastatic or recurrent disease. Levels of
thyroglobulin < 0.5 ng/ml have a negative predictive value of
98%.3,7 These patients then undergo surgical resection of the
thyroidgland followedby radioiodine ablation.8 The challenge
in our series was the patients presenting with distant metas-
tasis on the onset of the disease. During this period, these
conventionalmethodsofdiagnosing thyroidmalignancycould
not be employed; therefore, those patients underwent either a
formal biopsy or FNAC. Once diagnosed with thyroid metas-
tasis, they underwent total thyroidectomy.
Even though well-differentiated thyroid cancers have an
indolent nature, they may behave aggressively.3 The survival
rate varies for patients who present with distant metastasis
synchronously or metachronously with the primary tumor,
with the latter enjoying a better overall survival rate, with
the lesions appearing as late as a decade after the initial
diagnosis.3 Another study reports no signiﬁcant difference
between the overall survival amongst those with distant
metastasis at the time of presentation and those developing
it after the initial treatment.9 However, the disease-free
survival rate is better for those with distant metastasis at
the time of presentation.9 Regression analysis has shown
that local control of the disease is a signiﬁcant predictor of
the overall survival and disease-free survival rates.9
Due to the paucity of data on extra-cervical metastatic
thyroid cancer, there is a lack of consensus as to which
treatment should be prescribed for this metastatic disease.
According to the revised 2015 American Thyroid Association
Management Guidelines for Adult Patients with Thyroid No-
dulesandDifferentiatedThyroidCancer,RAI therapyshouldbe
employed; for bonemetastasis, the same can be done, but it is
rarely curative.10 There are no speciﬁc recommendations for
the treatment of metastases in sites other than these two.10
The use of RAI therapy for RAI-avid lesions is suggested.10 The
European consensus statement for the management of pa-
tients with differentiated thyroid carcinoma recommends the
use of surgery, external beam radiotherapy, and RAI ablation
for bone metastases.8 All of the patients in our series under-
went RAI ablation after thyroidectomy, except for the one
patient (case-1) who refused RAI.
Table 1 Patient demographics and treatment characteristics
Serial
number
Age Gender Comorbidities Initial
presentation
Specialty Surgery Histopathology Radioiodine
ablation
Case-1 45 Female  Left labia
majora lesion
Gynecology Total thyroidectomy þ
central neck dissection
Follicular
carcinoma
No
Case-2 35 Male  D12 vertebral
lesion
Neurosurgery Total thyroidectomy Follicular
carcinoma
Yes
Case-3 53 Male Hypertension,
asthma
Lung lesion Thoracic surgery Total thyroidectomy þ
central neck dissection
Papillary
carcinoma
Yes
Case-4 57 Male Diabetes,
hypertension,
ischemic heart
disease
Left iliac crest
lesion
Orthopedic
surgery
Total thyroidectomy þ
bilateral neck dissection
Follicular
carcinoma
Yes
Case-5 48 Female  Right
supraclavicular
lesion
Head and
neck surgery
Total thyroidectomy þ
bilateral neck dissection
Papillary
carcinoma
Yes
Case-6 65 Male Hypertension D10–11
vertebral lesion
Neurosurgery Total thyroidectomy þ
bilateral neck dissection
Papillary
carcinoma
Yes
Case-7 38 Male Hypertension Right
parapharyngeal
mass
Head and
neck surgery
Total thyroidectomy þ
central neck dissection
Papillary
carcinoma
Yes
Case-8 52 Male  Left third rib Thoracic surgery Total thyroidectomy þ
bilateral neck dissection
Follicular
carcinoma
Yes
Case-9 40 Female  Iliac crest Orthopedic
surgery
Total thyroidectomy þ
bilateral neck dissection
Papillary
carcinoma
Yes
Case-10 45 Male  Right femoral neck Orthopedic
surgery
Total thyroidectomy þ
central neck dissection
Papillary
carcinoma
Yes
Table 2 Follow-up and recurrence
Serial number Follow-up
(months)
Recurrence (yes/no)
Case-1 No follow-up Not available
Case-2 29 months No
Case-3 38 months No
Case-4 18 months No
Case-5 25 months Yes (thyroid bed)
Case-6 10 months Yes (lungs)
Case-7 49 months No
Case-8 52 months Yes (C7/T1)
Case-9 35 months No
Case-10 74 months Yes (L2 vertebrae)
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There is a lack of data on thyroid cancer presenting initially
with distant metastasis; therefore, no deﬁnitive guidelines are
available. Since the publication of the article by Song et al,4
various articles reporting such unusual presentations have
beenpublished, aswell asa recent systematic reviewondistant
metastasis of differentiated thyroid cancer,3,4 but more data
are required so that there is a consensus on the treatment of
these cases.
Conclusion
Distant metastasis in different thyroid malignancy is uncom-
mon. The usual site of the distant metastasis is either the lung
or the bones, andmetastases to organs other than these is rare.
The prognosis of the patients with distant metastasis is low,
providing a grim picture. Due to the lack of cases of patients
withdistantmetastasis reported in the literature, there are still
no deﬁnitive guidelines to treat these patients.We suggest and
encourage the collection ofmore data on such patients in order
to understand the natural history of the disease process and,
consequently, inorder tobeableto formulateguidelinesaiming
to help cliniciansmake the right choice when treating patients
with distant thyroid metastasis.
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